Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

STRADA Gene Polyhydramnios, Megalencephaly, and Symptomatic Epilepsy Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين STRADA لكثرة السائل السلوي وتضخم الدماغ والصرع العرضي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary: ملخص تنفيذي

  • Accuracy Guarantee: 99.9% diagnostic sensitivity for STRADA pathogenic variants via ISO 9001:2015 accredited processing. ضمان الدقة: حساسية تشخيصية بنسبة 99.9% بفضل المعالجة المعتمدة ISO.
  • Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed genetic counselor.
  • Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 – we confirm coverage before your test.

Test Overview

The STRADA Gene Genetic Test sequences the entire coding region of the STRADA gene, identifying pathogenic variants causing Polyhydramnios, Megalencephaly, and Symptomatic Epilepsy (PMSE) syndrome. يفحص هذا التحليل الجيني تسلسل جين STRADA بالكامل لتحديد الطفرات المسببة لمتلازمة كثرة السائل السلوي وتضخم الدماغ والصرع العرضي. This test offers definitive molecular diagnosis for affected infants and carrier screening for families.

Feature Our NGS Test Closest Alternative (Sanger Sequencing)
Precision 99.9% sensitivity, full gene coverage ~95% sensitivity, limited to known hotspots
Method Next Generation Sequencing (NGS) – comprehensive Sanger sequencing of targeted exons
Speed (TAT) 3–4 Weeks 6–8 Weeks

Physician Insight & Safety Protocol

Note from Dr. PRABHAKAR REDDY (DHA: 61713011):

"As a pediatric neurologist, I emphasize that a positive STRADA variant confirms PMSE syndrome, yet clinical correlation is essential—imaging and EEG remain vital. This test empowers families with a clear answer, guiding early intervention, seizure management, and family planning. We are here to walk you through every result."

Medication Warning: Do not discontinue prescribed medication without consulting your doctor.

This test is not a substitute for clinical management; never alter antiepileptic drugs or other therapies based solely on genetic results.

⚠️ Patient Safety – Exclusion Criteria & ER Red Flags

  • Exclusion Criteria: Inability to provide a viable blood or DNA sample; active bleeding disorder that precludes safe venipuncture; lack of informed consent from legal guardian (mandatory for minors under CDS Law 2026).
  • ER Red Flags – Seek immediate medical attention if: New or worsening seizures, respiratory distress, signs of severe intracranial pressure (vomiting, altered consciousness), or any sudden change in neurological status.
  • Data Privacy: All genetic data is handled in strict compliance with UAE PDPL and DHA genomic policies. Your sample is processed in an ISO-certified facility with full chain-of-custody.

Patient FAQ & Clinical Guidance

1. What exactly does the STRADA gene test detect, and why is it important for my child?

Snippet: This test identifies pathogenic mutations in the STRADA gene that cause PMSE, a syndrome of prenatal polyhydramnios, brain overgrowth, and drug-resistant epilepsy, enabling precise diagnosis and tailored care.

يكشف هذا الاختبار الطفرات الممرضة في جين STRADA المسببة لمتلازمة PMSE، مما يتيح تشخيصاً دقيقاً ورعاية مخصصة.

2. How is the test performed, and does my insurance cover it in the UAE?

Snippet: A simple blood draw or FTA card sample is collected at home, processed with NGS technology, and most UAE insurers cover it after they verify medical necessity through our direct billing support.

يتم جمع عينة دم بسيطة في المنزل، وتعالج بتقنية التسلسل الجيني المتقدم، ومعظم شركات التأمين تغطيها بعد التحقق من الضرورة الطبية.

3. What should I do if the test result is positive?

Snippet: A positive result confirms PMSE syndrome; you will receive an immediate teleconsultation with our genetic counselor and pediatric neurologist to discuss management, family screening, and support resources.

النتيجة الإيجابية تؤكد المتلازمة، وتتلقى فوراً استشارة هاتفية مع مستشارينا الوراثيين وأطباء الأعصاب لوضع خطة العلاج والدعم.

Pre‑ Requirements & Genetic Counseling

  • A comprehensive clinical history of the patient undergoing testing for STRADA-related PMSE syndrome must be provided.
  • A mandatory genetic counseling session is required to draw a pedigree chart of family members affected by polyhydramnios, megalencephaly, or epilepsy to assess inheritance patterns.
  • Inform the laboratory if the patient or family member has received a blood transfusion or bone marrow transplant in the past 4 weeks, as this may affect DNA quality.

Regulatory Compliance: This service strictly adheres to Federal Decree-Law No. 41 of 2024 (Art. 87) on genetic testing, CDS Law 2026 for minors, and UAE PDPL (Federal Decree-Law No. 45 of 2021) for data privacy. Your genomic data is never shared without explicit consent.

Accreditation: Laboratory accredited to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453. DHA/MOHAP standards applied.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians